Scarica l'app Stockscreener
5.44
4.62%
0.24
Dopo l'orario di chiusura:
5.65
0.21
+3.86%
Precedente Chiudi:
$5.20
Aprire:
$5.15
Volume 24 ore:
851.70K
Relative Volume:
1.43
Capitalizzazione di mercato:
$715.39M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-136.00
EPS:
-0.04
Flusso di cassa netto:
$454.00K
1 W Prestazione:
+13.10%
1M Prestazione:
+7.51%
6M Prestazione:
-12.54%
1 anno Prestazione:
+23.92%
Intervallo 1D:
$5.115
$5.54
Intervallo di 1 settimana:
$4.77
$5.54
Portata 52W:
$3.80
$9.87
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings: Revenue Hits $51. - GuruFocus.com
Cytek Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Preview: Cytek Biosciences's Earnings - Benzinga
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Biosciences (CTKB) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024 - GlobeNewswire
Cytek® Biosciences automates panel design with new intelligent algorithm - MSN
Layoff Tracker: Dublin-Based CRO With US Offices Signals Upcoming Layoffs - BioSpace
(CTKB) Trading Report - Stock Traders Daily
The Manufacturers Life Insurance Company Purchases 2,460 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Up 5.4% in September - MarketBeat
Institutional investors have a lot riding on Cytek Biosciences, Inc. (NASDAQ:CTKB) with 53% ownership - Simply Wall St
What technical indicators reveal about CTKB stock - US Post News
Cytek BioSciences Inc (CTKB) Becoming More Attractive for Investors - Knox Daily
Millennium Management LLC Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Shares Up 3.6%Still a Buy? - MarketBeat
Analysts review Cytek BioSciences Inc’s rating - Knox Daily
Examining Cytek BioSciences Inc (CTKB) more closely is necessary - US Post News
Quarterly Snapshot: Quick and Current Ratios for Cytek BioSciences Inc (CTKB) - The Dwinnex
When the Price of (CTKB) Talks, People Listen - Stock Traders Daily
Squarepoint Ops LLC Acquires 170,539 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Renaissance Technologies LLC Makes New $1.31 Million Investment in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Algert Global LLC - MarketBeat
Selling Buzz: Cytek BioSciences Inc [CTKB] CHIEF TECHNOLOGY OFFICER Yan Ming sells 20,000 shares of the company – Knox Daily - Knox Daily
Cytek BioSciences Inc (CTKB) can make a big difference with a little luck - SETE News
Stock Performance Spotlight: Cytek BioSciences Inc (CTKB) Ends the Day at 5.24, Down by -2.78 - The Dwinnex
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Public Sector Pension Investment Board - Defense World
American Century Companies Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Dark Forest Capital Management LP Purchases 9,711 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Technical analysis of Cytek BioSciences Inc (CTKB) stock chart patterns - US Post News
Deerfield Management Company L.P. Series C Purchases Shares of 155,759 Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Jumia Technologies (NYSE:JMIA) Shares Gap Up to $5.21 - Defense World
Where are the Opportunities in (CTKB) - Stock Traders Daily
Investor’s Delight: Cytek BioSciences Inc (CTKB) Closes Strong at 5.19, Up 1.96 - The Dwinnex
Cytek BioSciences Inc (CTKB)’s stock performance: a year in review - US Post News
Texas Permanent School Fund Corp Sells 12,539 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Rhumbline Advisers - Defense World
Cytek Biosciences (NASDAQ:CTKB) Shares Down 2.6% - MarketBeat
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) - GlobeNewswire
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe - Yahoo Finance
Single Cell Analysis Market Expansion: Key Research, Trends, and Strategies Powering Growth to $6.9 Billion... - WhaTech
Cytek Biosciences (NASDAQ:CTKB) Trading 5.5% Higher - MarketBeat
Results from Cytek BioSciences Inc (CTKB) show potential - US Post News
Investor’s Toolkit: Key Ratios for Assessing Cytek BioSciences Inc (CTKB)’s Performance - The Dwinnex
Natixis Advisors LLC Makes New Investment in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Bank of New York Mellon Corp Purchases 29,579 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Egle names Detheux chairman - BioCentury
CTKB’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Shares Not Telling The Full Story - Simply Wall St
(CTKB) Technical Pivots with Risk Controls - Stock Traders Daily
Cytek Biosciences (NASDAQ:CTKB) Stock Price Down 3.8% - MarketBeat
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cytek Biosciences Inc Azioni (CTKB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Apr 09 '24 |
Sale |
7.00 |
1,900 |
13,304 |
6,008,502 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 18 '24 |
Sale |
6.77 |
20,000 |
135,400 |
6,030,402 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 19 '24 |
Sale |
6.71 |
20,000 |
134,200 |
6,010,402 |
| Jeanmonod Patrik | Chief Financial Officer |
Dec 26 '23 |
Sale |
9.50 |
3,000 |
28,500 |
93,400 |
| Yan Ming | Chief Technology Officer |
Dec 19 '23 |
Sale |
9.43 |
20,000 |
188,600 |
6,042,103 |
| Jeanmonod Patrik | Chief Financial Officer |
Nov 24 '23 |
Sale |
6.94 |
3,000 |
20,820 |
96,400 |
| Yan Ming | Chief Technology Officer |
Nov 20 '23 |
Sale |
6.03 |
20,000 |
120,600 |
7,762,103 |
| Jiang Wenbin | President and CEO |
Nov 07 '23 |
Sale |
4.34 |
20,000 |
86,800 |
5,275,796 |
0.47%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):